In today's episode we'll give you a quick lowdown on what's happening with Microsoft’s $75 billion takeover of Activision Blizzard. Right from FTC trying to block the deal to Sony and Microsoft signing a deal where both parties agreed to keep Call of Duty on Playstation for 10 years after the proposed Activision Blizzard acquisition.
In other news, a new drug called donanemab from Eli Lilly has shown promise in slowing down the advancement of Alzheimer's disease.
For this and more tune in To The Signal Daily!
The Signal Daily is produced in association with IVM.
The episode was written and researched by Anup and Sneha
Edited by Dinesh Narayanan
Produced by Manaswini
Mastered and mixed by Manas and Nirvaan
You can check out our website at https://ivmpodcasts.com/.
Do follow IVM Podcasts on social media.
Follow the show across platforms:
See omnystudio.com/listener for privacy information.